AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
The Barriers to Clinical Research in Inpatient or Outpatient Environments for Repurposed Multi Drug Strategies
Ivermectin is a prophylactic, I think that's a slam dunk treating it with the drugs you've got. Why are we not focused on antivirals? Okay. Tamiflu is the best way to express that. The history, long history of coming up with strategies for treating pulmonary viral infections at the level of an antiviral agent is horrible. It basically doesn't work. We're trying to advance a two drug and three drug strategy with US government funding through the FDA because my, the source of this capital is coming from the department of defense.